Skip to Content

3QD (Viekira XR dasabuvir 200 mg / ombitasvir 8.33 mg / paritaprevir 50 mg / ritonavir 33.33 mg)

Generic Name: dasabuvir/ombitasvir/paritaprevir/ritonavir

Pill imprint 3QD has been identified as Viekira XR dasabuvir 200 mg / ombitasvir 8.33 mg / paritaprevir 50 mg / ritonavir 33.33 mg.

Viekira XR is used in the treatment of hepatitis c and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Viekira XR dasabuvir 200 mg / ombitasvir 8.33 mg / paritaprevir 50 mg / ritonavir 33.33 mg is not a controlled substance under the Controlled Substance Act (CSA).

Viekira XR
Generic Name:
dasabuvir/ombitasvir/paritaprevir/ritonavir
Imprint:
3QD
Strength:
dasabuvir 200 mg / ombitasvir 8.33 mg / paritaprevir 50 mg / ritonavir 33.33 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiviral combinations
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
AbbVie Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide